Parameswaran Venugopal to Azacitidine
This is a "connection" page, showing publications Parameswaran Venugopal has written about Azacitidine.
Connection Strength
0.050
-
Results of a randomized phase 3 study of oral sapacitabine in elderly patients with newly diagnosed acute myeloid leukemia (SEAMLESS). Cancer. 2021 12 01; 127(23):4421-4431.
Score: 0.050